1. Home
  2. Article

Magnesium glycinate attenuates cyclophosphamide-induced ovarian toxicity in Wistar rats

Research Paper

Magnesium glycinate attenuates cyclophosphamide-induced ovarian toxicity in Wistar rats

Luqman Adepoju Hassan, Foluso Olamide Ojo, Rasheed Tunde Lawal, Omoola Oluwatosin Olasheu, Abdul-Raheem Folorunsho Ahmad, Kolade Pelumi Folorunso, Idowu Oluwagbemiga Coker, Sirajudeen Olasunkanmi Bashir, Mistura Bolaji Ajani, Tolulope Mary Onaolapo, Aishat Abidemi Olawale, Muhsinat Bisola Lawal1, Oluwafemi Samuel Olaniyi

Cyclophosphamide (CP) is an alkylating chemotherapy agent that causes severe, dose-limiting ovotoxicity, often leading to diminished ovarian reserve. This study investigated the protective efficacy of magnesium glycinate (MgG), a highly bioavailable organic magnesium chelate with antioxidant properties, against CP-induced structural and endocrine ovarian damage. Forty-eight adult female Wistar rats were divided into six groups (n=8): Control, MgG Low-Dose (22.8 mg/kg), MgG High-Dose (32.8 mg/kg), CP-Only (150 mg/kg i.p. on days 1, 3, and 5), and CP co-administered with low or high-dose MgG orally for 21 days. Serum follicle-stimulating hormone (FSH) and luteinizing hormone (LH) were quantified via ELISA. Ovarian histoarchitecture, stromal fibrosis, and glycoprotein barrier integrity were evaluated utilizing Hematoxylin & Eosin, Masson’s Trichrome, and Periodic Acid-Schiff staining. CP intoxication profoundly disrupted the hypothalamic-pituitary-ovarian axis, significantly suppressing serum FSH and LH levels (p < 0.05). Histologically, CP induced massive interstitial hemorrhage, vascular congestion, extensive stromal fibrosis, and the degradation of glycoprotein microenvironments (follicular basement membrane and zona pellucida). Co-administration of MgG dosedependently attenuated these toxicities. The high-dose MgG regimen normalized LH concentrations, upregulated FSH secretion, prevented hemorrhagic necrosis, suppressed aberrant collagen cross-linking, and preserved the structural integrity of critical glycoprotein barriers and developing follicles. Magnesium glycinate successfully mitigates CP-induced ovotoxicity by rescuing vital gonadotropin secretion, suppressing pathological extracellular matrix remodeling, and preserving essential follicular microenvironments, positioning it as a promising adjunct therapy for fertility preservation during gonadotoxic chemotherapy.

Key Words: Cyclophosphamide; ovarian toxicity; magnesium glycinate; oxidative stress; fertility preservation

Download PDF